Semaglutide vs CJC-1295 No DAC + Ipamorelin
The incretin route against the growth-hormone route — the sharpest split in the catalogue.
Side by side
- SemaglutideIn stock
- Purity
- ≥98%release spec
- Sizes
- 5 mgsold out10 mg
- Price / mg
- €5.00 / mg
- CJC-1295 No DAC + IpamorelinIn stock
- Purity
- ≥98%release spec
- Sizes
- 10 mg + 10 mg
- Price / mg
- €7.50 / mg
Every figure here is read from the catalogue when the page loads. Where a number is not documented — a purity specification we never published, a price per milligram for a vial sold in international units — the cell stays empty rather than being filled.
What you are actually choosing between
Two routes to a body-composition question that share no mechanism at all.
Semaglutide is a GLP-1 receptor agonist: 31 amino acids on a modified GLP-1 backbone, acylated with a fatty-acid chain that binds albumin and stretches the half-life toward a week, which is why the published protocols are weekly. Its research concerns incretin signalling — appetite regulation, gastric emptying, glucose handling. It is the most heavily studied compound in this catalogue by a wide margin.
The CJC-1295 No DAC and ipamorelin blend works nowhere near any of that. It pairs a modified GHRH 1-29 analogue with a selective ghrelin-receptor pentapeptide, hitting the pituitary through two receptors at once, and its subject is the growth-hormone axis. Note what the blend does and does not offer: the evidence base belongs to the two individual peptides, not to the combination as supplied, and combination-specific human data is not what is being pointed at when either component is cited.
So this is the incretin pathway or the growth-hormone pathway. They are not additive views of one problem and there is no dose at which one substitutes for the other.
Practically, the blend holds fourteen days refrigerated once reconstituted; semaglutide is stored at 2–8 °C and reconstituted before use. Purity, sizes, price per milligram and current availability above come from the live catalogue at page load.
Both are supplied for laboratory research only. Neither is sold for human or veterinary use.
Both compounds can be shipped today.
Related comparisons
- Semaglutide vs Tirzepatide vs RetatrutideOne receptor, two, or three — and how much evidence sits behind each.
- Retatrutide vs TirzepatideThe head-to-head the three-way article covers only in passing, and the highest-volume pairing in the category.
- Semaglutide vs RetatrutideThe established single-agonist against the triple — the pairing our own stock actually supports.
- Semaglutide vs TesamorelinThe largest human dataset in the category against the most narrowly defined one.
Peptyds supplies these materials for laboratory research only. They are not sold for human or veterinary use, and nothing on this page describes an outcome. All comparisons · Quality protocol